BioSymetrics, an artificial intelligence and machine learning SaaS company, announced yesterday that it has named Dr Calum MacRae as its new senior advisor.

Dr MacRae is a pioneer in genetics, biology, and drug discovery. He will assist BioSymetrics in the design and application of the company's software for use in drug discovery, precision medicine and health systems.

He is the vice chair for Scientific Innovation at the Department of Medicine at Brigham and Women's Hospital and associate professor of medicine at Harvard Medical School. He is also the leader of the One Brave Idea initiative, a diverse team of scientists, together with the latest technologies and scientific advances, with a mission to find the weapons and strategies to win the fight against coronary heart disease.